Clinical trial
Real World Study of the Tendyne™ Mitral Valve System to Treat Mitral Regurgitation (RESOLVE-MR) (Tendyne™ PMCF Study)
NCT04818502 is registered in ClinicalTrials.gov with Abbott Medical Devices as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Real World Study of the Tendyne™ Mitral Valve System to Treat Mitral Regurgitation (RESOLVE-MR) (Tendyne™ PMCF Study)
- Lead sponsor
- Abbott Medical Devices
- Phase
- Observational
- Overall status
- Active, not recruiting
- Start date
- May 4, 2021
- Completion date
- May 31, 2028
- Enrollment
- 200 (estimated)
- Sites
- 36
Conditions
As the registry lists them; a condition with its own page is linked.
mitral valve regurgitation